The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The role of cytoreductive nephrectomy (CN) in the immune checkpoint inhibitor (ICI) era of metastatic renal cell carcinoma (mRCC): A systematic review and individual patient data (IPD) meta-analysis of 2319 patients.
 
Dimitrios Makrakis
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Pavlos Msaouel
Honoraria - Exelixis; Mirati Therapeutics; Pfizer
Consulting or Advisory Role - Axiom Healthcare Strategies
Research Funding - Bristol-Myers Squibb (Inst); Gateway for Cancer Research (Inst); Mirati Therapeutics (Inst); Takeda (Inst)
 
Jose A. Karam
Stock and Other Ownership Interests - Medtek; ROM Tech
Consulting or Advisory Role - Johnson & Johnson/Janssen; Merck; Pfizer
Research Funding - Elypta; Merck; Mirati Therapeutics; Roche/Genentech
Travel, Accommodations, Expenses - Pfizer
 
Stepan M. Esagian
No Relationships to Disclose